Editorial: Advances and Challenges in Nanomedicine

scientific article published on 29 November 2018

Editorial: Advances and Challenges in Nanomedicine is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.3389/FPHAR.2018.01397
P932PMC publication ID6281879
P698PubMed publication ID30555328

P2093author name stringSusan Hua
Sherry Y Wu
P2860cites workQuo vadis nanomedicine?Q50611624
Challenges and strategies in anti-cancer nanomedicine development: An industry perspectiveQ26748018
Advances and Challenges of Liposome Assisted Drug DeliveryQ26773160
Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory DiseasesQ28548580
Drug delivery systems: entering the mainstreamQ29618136
Overcoming the Challenges of siRNA Delivery: Nanoparticle StrategiesQ36107293
Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacyQ39066848
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectnanomedicineQ261659
P304page(s)1397
P577publication date2018-11-29
P1433published inFrontiers in PharmacologyQ2681208
P1476titleEditorial: Advances and Challenges in Nanomedicine
P478volume9

Reverse relations

Q98176943Plasma polymerized nanoparticles effectively deliver dual siRNA and drug therapy in vivocites workP2860

Search more.